https://prabadinews.com/
  • October 9, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety

Elranatamab combined with daratumumab and lenalidomide shows promising results for treating newly diagnosed multiple myeloma, enhancing patient outcomes.

administrator

Related Articles